Compare WhiteOak Capital Pharma and Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.57
2.11
NAV
₹15.95
₹45.09
Fund Started
16 Jan 2024
25 Jun 2018
Fund Size
₹664.02 Cr
₹6453.52 Cr
Exit Load
-
Exit load of 1% if redeemed within 15 days.
1 Year
14.48%
5.40%
3 Year
-
26.73%
5 Year
-
15.16%
Equity
99.10%
99.82%
Cash
-7.04%
0.18%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.56% |
JB Chemicals & Pharmaceuticals Ltd. | 6.80% |
Apollo Hospitals Enterprise Ltd. | 4.83% |
Laurus Labs Ltd. | 4.43% |
Fortis Healthcare Ltd. | 3.92% |
Krishna Institute of Medical Sciences Ltd | 3.44% |
Divi's Laboratories Ltd. | 3.29% |
Sai Life Sciences Ltd. | 3.17% |
Max Healthcare Institute Ltd. | 2.83% |
Aurobindo Pharma Ltd. | 2.62% |
Sun Pharmaceutical Industries Ltd. | 12.09% |
Dr. Reddy's Laboratories Ltd. | 7.70% |
Cipla Ltd. | 7.45% |
Mankind Pharma Ltd. | 7.03% |
Divi's Laboratories Ltd. | 6.06% |
Biocon Ltd. | 4.71% |
Cohance Lifesciences Ltd. | 4.37% |
Alkem Laboratories Ltd. | 4.08% |
Medplus Health Services Ltd. | 3.86% |
Max Healthcare Institute Ltd. | 3.36% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
16 Jan 2024
25 Jun 2018
